David Spaner

7.7k citations
131 papers · 6.6k · 2 hit papers · h-index 38

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Mesenchymal stem cell research
  • Oncology top 1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Chronic Lymphocytic Leukemia Research 56
    • T-cell and B-cell Immunology 14
    • Immunotherapy and Immune Responses 12
    • Immune Response and Inflammation 3

David Spaner

125 papers receiving 6.4k citations

David Spaner's Hit Papers

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor 2014 · 1.4k citations
1.4k0+5+10Years since publication4008001.2k

Peers

David Spaner
Comparison fields: 5 of 110
  • Genetics 1.3k
  • Oncology 2.4k
  • Immunology 1k
  • Hematology 476
  • Pathology and Forensic Medicine 590
Replace James G. Karras with:
James G. Karras United States
Taghi Manshouri United States
Lynn C. Moscinski United States
Kevin D. Bunting United States
Osamu Miura Japan
Martina Seiffert Germany
Keisuke Kataoka Japan
Wei Xu China
Rebecca Elstrom United States
Wolfgang Oster Germany
David Spaner relative to James G. Karras United States James G. Karras's profile →
Citations per field
00.5×2×3×3.9×
James G. Karras · 1×
Citations per year

Countries citing papers authored by David Spaner

Since Specialization
Citations

This map shows the geographic impact of David Spaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Spaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Spaner more than expected).

Fields of papers citing papers by David Spaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Spaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Spaner. The network helps show where David Spaner may publish in the future.

Co-authors

The 25 scholars most cited alongside David Spaner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Spaner Line = papers co-authored together David Spaner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
Hit paper breakdown →
20141385
2
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
Hit paper breakdown →
20111250
3 2006341
4 2009244
5 1989126
6 2010125
7 2010113
8 2016106
9 200394
10 200686
11 201386
12 201283
13 200481
14 201078
15 200573
16 201272
17 201670
18 199964
19
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
199961
20 201260

About David Spaner

David Spaner is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Hematology and Oncology, having authored 131 papers that have together received 6.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (56 papers), Lymphoma Diagnosis and Treatment (20 papers), T-cell and B-cell Immunology (14 papers), Hematopoietic Stem Cell Transplantation (12 papers), Immunotherapy and Immune Responses (12 papers), Peroxisome Proliferator-Activated Receptors (5 papers), CAR-T cell therapy research (4 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Genetics (1.3k citations), Oncology (2.4k citations), Immunology (1k citations), Hematology (476 citations) and Pathology and Forensic Medicine (590 citations). David Spaner has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Yonghong Shi, Debbie-Ann N. Nathan, Irina Marić, Steven A. Rosenberg, Steven A. Feldman, Giao Q. Phan, James N. Kochenderfer, Wyndham Hopkins Wilson, James Chih-Hsin Yang and Mark E. Dudley. Their work appears in journals such as Blood, Leukemia, The Journal of Immunology, Bone Marrow Transplantation and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact